Loading…
Aligos Therapeutics, Inc. is projected to rise to $6.68 by 2027, a +1% move from its current price of $6.62. ALGS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $6.38 | $6.63 | $6.88 | +0.08% |
| Jul 15 | $6.28 | $6.63 | $7.00 | +0.17% |
| Jul 16 | $6.21 | $6.64 | $7.09 | +0.25% |
| Jul 17 | $6.16 | $6.64 | $7.17 | +0.33% |
| Jul 18 | $6.11 | $6.65 | $7.24 | +0.41% |
| Jul 19 | $6.06 | $6.65 | $7.30 | +0.50% |
| Jul 20 | $6.02 | $6.66 | $7.36 | +0.58% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.02 | $6.66 | $7.36 | +0.58% |
| Week 2 | $5.81 | $6.70 | $7.72 | +1.16% |
| Week 3 | $5.66 | $6.74 | $8.02 | +1.75% |
| Week 4 | $5.54 | $6.77 | $8.28 | +2.34% |
| Week 5 | $5.44 | $6.81 | $8.53 | +2.93% |
| Week 6 | $5.36 | $6.85 | $8.77 | +3.52% |
| Week 7 | $5.28 | $6.89 | $8.99 | +4.12% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate ALG-055009 is a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis and obesity.
The company also develops pevifoscorvir sodium, a capsid assembly modulator, which is in Phase 2 B clinical trial; and ALG-097558, a small molecule ritonavir-free pan-coronavirus protease inhibitor which has completed a Phase 1 clinical trial for the treatment of coronavirus. The company has entered into license and research collaboration agreement with Emory University; and Katholieke Universiteit Leuven. Aligos Therapeutics, Inc.
was incorporated in 2018 and is headquartered in South San Francisco, California.
ALGS is the stock symbol for Aligos Therapeutics, Inc. The current price is $6.73 and the company carries a market capitalization of $41.65M, with a rank of 4639. The stock operates in the Healthcare sector.
A major floor 36.0% below — a decisive break under it would weaken the trend.
The nearest floor, 25.8% below — buyers have tended to step in here.
Price is pressing into resistance (2.3% away) — a breakout level to watch.
A major ceiling 32.0% above — clearing it would confirm fresh momentum.
Key ALGS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALGS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.41 | Buy | $6.43 | Buy |
| MA 10 | $5.99 | Buy | $6.13 | Buy |
| MA 20 | $5.68 | Buy | $5.87 | Buy |
| MA 50 | $5.73 | Buy | $5.94 | Buy |
| MA 100 | $6.45 | Buy | $6.48 | Buy |
| MA 200 | $7.76 | Sell | $7.59 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.91 | Neutral |
| Stoch RSI (14) | 82.92 | Sell |
| CCI (20) | 166.50 | Buy |
| Williams %R (14) | -11.19 | Info |
| MACD (12,26,9) | 0.17 | Buy |
| ROC (12) | 17.17 | Buy |
| Bollinger %B (20,2) | 0.97 | Neutral |
| Stochastic %K (14) | 88.81 | Sell |
| TRIX (15) | 0.15 | Buy |
| Awesome (5,34) | 0.85 | Buy |
| Ultimate (7,14,28) | 71.34 | Sell |
| Momentum (10) | 1.12 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 6.90 | Sell |
| ADX (14) | 16.44 | Neutral |
| ATR (14) | 0.21 | Info |
The 30-day technical picture is described as BULLISH, with RSI14 at 70. The stock trades with a SMA50 of $5.72 and a SMA200 of $7.79. Immediate support sits at $4.91 and resistance at $6.73. The 30-day price range runs from a low of $5.17 to a high of $8.77.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.91 | $6.62 | $9.00 | 0% | Neutral | |
| $5.12 | $6.68 | $9.31 | +1% | Neutral | |
| $5.01 | $6.80 | $9.96 | +3% | Neutral | |
| $5.69 | $7.99 | $12.15 | +21% | Bullish | |
| $5.84 | $8.46 | $13.27 | +28% | Bullish | |
| $7.18 | $10.69 | $17.24 | +61% | Bullish | |
| $8.14 | $12.43 | $20.54 | +88% | Bullish | |
| $7.30 | $11.44 | $19.31 | +73% | Bullish | |
| $7.27 | $11.66 | $20.10 | +76% | Bullish | |
| $7.30 | $11.98 | $21.03 | +81% | Bullish | |
| $10.49 | $19.15 | $36.31 | +189% | Bullish | |
| $18.26 | $40.48 | $85.70 | +511% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.91 | $6.62 | $8.09 | +0.00% |
| August 2026 | $5.93 | $7.08 | $8.72 | +6.92% |
| September 2026 | $5.93 | $7.14 | $8.93 | +0.83% |
| October 2026 | $5.64 | $6.85 | $8.68 | -4.00% |
| November 2026 | $5.59 | $6.84 | $8.76 | -0.20% |
| December 2026 | $5.65 | $6.96 | $9.00 | +1.83% |
Click any year to see its month-by-month ALGS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ALGS could reach as high as $9.00, with a base case around $6.62 and support toward $4.91 — roughly 0% from $6.62. Price action looks broadly range-bound.
Expect ALGS to range from $5.12 to $9.31 through 2027. The $6.68 average target implies a +1% move from current prices. That is up +1% on the projected 2026 average. A consolidation phase looks the most probable path here.
The ALGS price prediction for 2028 points to an average of $6.80 (low $5.01, high $9.96) — a potential gain of +3% on today's $6.62. Price action looks broadly range-bound.
In 2029, ALGS is projected to trade between $5.69 and $12.15, averaging $7.99 — a potential gain of +21% from today's $6.62. That is up +17% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Aligos Therapeutics, Inc.'s 2030 outlook centres on $8.46, within a $5.84 to $13.27 range. That is up +6% on the projected 2029 average. That marks a +28% change versus current levels. Momentum favours further upside here.
By 2031, ALGS could reach as high as $17.24, with a base case around $10.69 and support toward $7.18 — roughly +61% from $6.62. Buyers look set to stay in control over this stretch.
Expect ALGS to range from $8.14 to $20.54 through 2032. The $12.43 average target implies a +88% move from current prices. That is up +16% on the projected 2031 average. Momentum favours further upside here.
The ALGS price prediction for 2033 points to an average of $11.44 (low $7.30, high $19.31) — a potential gain of +73% on today's $6.62. Buyers look set to stay in control over this stretch.
In 2034, ALGS is projected to trade between $7.27 and $20.10, averaging $11.66 — a potential gain of +76% from today's $6.62. That is up +2% on the projected 2033 average. Momentum favours further upside here.
Aligos Therapeutics, Inc.'s 2035 outlook centres on $11.98, within a $7.30 to $21.03 range. That is up +3% on the projected 2034 average. That marks a +81% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ALGS could reach as high as $36.31, with a base case around $19.15 and support toward $10.49 — roughly +189% from $6.62. Momentum favours further upside here.
Expect ALGS to range from $18.26 to $85.70 through 2050. The $40.48 average target implies a +511% move from current prices. That is up +111% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ALGS today (≈ 151.057402 ALGS) could be worth
$6,114.23
+$5,114.23 (+511%) by 2050 · US Dollar
Based on the average projected ALGS price of $40.48 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALGSwould be worth at today's price.
$1,000 invested in ALGS on Jul 10, 2025 (≈ 113.765643 ALGS) would be worth
$753.13
-$246.87 (-24.7%) today · 0.75× · US Dollar
Based on a ALGS entry price of $8.79 vs. today's $6.62.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.59 | $1,184.26 | +18.4% |
| 1 month ago | $5.16 | $1,282.95 | +28.3% |
| 3 months ago | $7.99 | $828.02 | -17.2% |
| 6 months ago | $8.71 | $760.05 | -24.0% |
| 1 year ago | $8.79 | $753.13 | -24.7% |
| All time (5.0y) ago | $379.75 | $17.43 | -98.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALGS forecast.
Our base-case forecast reaches $13.00 around 2040.
Implied market cap at $13.00: $70.05M
The multi-year forecast shows a path of growth with varying sentiment across years. In 2026 the average price is projected at $6.73 (range $4.91 to $9.18) with ROI of 0 and NEUTRAL sentiment. By 2030 the average is forecast at $8.18 with a 21.5% ROI and BULLISH sentiment.
The trajectory continues with 2031 at $10.51 (56.2% ROI), 2032 at $12.24 (81.8% ROI), 2033 at $11.05 (64.2% ROI), 2034 at $11.29 (67.7% ROI), and 2035 at $11.51 (71.0% ROI). Further out, 2040 is seen at an average of $18.41 (173.6% ROI) and 2050 at $38.21 (467.8% ROI), both with BULLISH sentiment. These figures are forecasts and not guarantees, and actual results may vary.
Tap a question to reveal the answer.
2030's forecast shows an average price of $8.18 with a min of $5.57 and a max of $13.03, and a 21.5% ROI; sentiment is BULLISH.
The forecast indicates a long-term bullish path, with averages rising to $38.21 by 2050 and a 467.8% ROI, but these are estimates and not guarantees; investing involves risk.
Yes, the 2031 forecast lists an average of $10.51, with a min of $6.95 and a max of $17.23, reflecting a 56.2% ROI and BULLISH sentiment.
The current price is $6.73 and the market capitalization is $41.65M, with a rank of 4639.
The 30-day range is $5.17 to $8.77. RSI14 is 70, with support at $4.91 and resistance at $6.73.
Aligos Therapeutics, Inc. Community Discussion
0Share your Aligos Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.